These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7250546)

  • 1. Oral contraceptives and birth defects.
    Smithells RW
    Dev Med Child Neurol; 1981 Jun; 23(3):369-72. PubMed ID: 7250546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal exposure to exogenous sex hormones in relation to birth weight of offspring.
    Polednak AP; Janerich DT; Glebatis DM
    Teratology; 1983 Apr; 27(2):223-9. PubMed ID: 6867944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pill taken during or just before pregnancy not linked to various birth defects; need more study on heart ills.
    Fam Plann Perspect; 1977; 9(3):132-3. PubMed ID: 862834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraceptive hormones and congenital heart disease.
    Nora JJ; Nora AH
    Teratology; 1977 Jun; 15(3):331-2. PubMed ID: 882922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fertility and characteristics of ovulation after discontinuing oral contraception].
    Gaspard U; Lambotte R
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1005-10. PubMed ID: 12266509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
    Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H; Norpoth T; Michaels MA
    Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are contraceptive pills teratogenic?
    Czeizel A
    Acta Morphol Acad Sci Hung; 1980; 28(1-2):177-88. PubMed ID: 7446219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of oral contraceptives on developmental anomalies and on the sex ratio of newborn infants].
    Pejtsik B; Hadnagy J; Rappai G; Kóbor J
    Orv Hetil; 1990 Jun; 131(22):1187-90. PubMed ID: 2192336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
    Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
    Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives.
    Rosenberg MJ; Waugh MS; Long S
    J Reprod Med; 1995 May; 40(5):355-60. PubMed ID: 7608875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies.
    Bracken MB
    Obstet Gynecol; 1990 Sep; 76(3 Pt 2):552-7. PubMed ID: 2143279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.